800
Participants
Start Date
September 17, 2025
Primary Completion Date
June 7, 2028
Study Completion Date
June 7, 2028
Trontinemab
Participants will receive IV trontinemab.
Placebo
Participants will receive IV placebo.
RECRUITING
Charter Research - Lady Lake/The Villages, The Villages
RECRUITING
Conquest Research, LLC, Winter Park
RECRUITING
Renstar Medical Research, Ocala
RECRUITING
Irvine Center for Clinical Research, Irvine
RECRUITING
Basil Clinical, Laurelton
RECRUITING
Toronto Memory Program, Toronto
RECRUITING
National Hospital Organization Utano National Hospital, Kyoto
RECRUITING
Yamagata Tokusyukai Hospital, Yamagata
RECRUITING
Recognition Health Bristol, Bristol
RECRUITING
Surrey and Borders NHS Foundation Trust, Chertsey
RECRUITING
RE:Cognition Health, London
Hoffmann-La Roche
INDUSTRY